Accepted at 6:36 p.m. Oct, 31, 2023 by dollajas
Author: herstein.jacob
Related Note: 1543504724150
Rationale for change

added SGLT2 note in extra & fixed extra formatting (picture was breaking up the existing text)

Extra Extra
Additional Resources Additional Resources
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
Empty field
OME
One by one
Empty field
#AK_Step1_v12::#AMBOSS::02aeTP #AK_Step2_v12::#Resources_by_rotation::IM::uw::endocrine_diabetes_metabolism::endocrine_diabetes_metabolism_dorian #AK_Step1_v12::#B&B::09_Endocrinology::03_Pancreas::06_Treatment_of_Diabetes_Mellitus #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::02_Metformin,_Thiazolidinediones,_Pramlintide,_SGLT2_Inhibitors #AK_Step1_v12::#Pixorize::03_Pharmacology::08_Diabetes_Drugs_(Old)::07_GLP-1_Analogs #AK_Step2_v12::Original_decks::Dorian::im::ome::endo::outpatient_dm #AK_Step3_v12::#UWorld::107729 #AK_Step2_v12::#AMBOSS::OBaIaM #AK_Step2_v12::#UWorld::Step::16507 #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Endocrinology::Outpatient_Type_2_Diabetes_Mellitus #AK_Step2_v12::#Resources_by_rotation::IM::ome::endo::outpatient_dm #AK_Step2_v12::#B&B::04_Endocrinology::03_Diabetes::05_Diabetes_Treatment::Extra #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::06_Retired_Lessons::03_Metformin,_thiazolidinediones,_pramlintide,_SGLT2_inhibitors_[Retired_Video] #AK_Step2_v12::#UWorld::COMLEX::103504 #AK_Step2_v12::Original_decks::Dorian::im::uw::endocrine #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::02_GLP-1_Analogs #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::09_SGLT2_Inhibitors #AK_Step2_v12::#Resources_by_rotation::FM::ome::endo::outpatient_dm #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::Endocrine,_Diabetes,_&_Metabolism #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::01_Insulin,_sulfonylureas,_meglitinides,_GLP-1_agonists,_DPP-4_inhibitors #AK_Step2_v12::#UWorld::#UWSA1 #AK_Step2_v12::#Subjects::Endocrinology::06_Pancreas::Diabetes::*Management_REDO #AK_Step3_v12::#UWorld::5061 #AK_Step2_v12::Original_decks::Dorian::fam::ome::endo::outpatient_dm #AK_Step2_v12::#AMBOSS::8E0Ox3 #AK_Step2_v12::!Shelf::FM #AK_Step2_v12::#UWorld::Step::6921 #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::02_Diabetes_Management #AK_Step2_v12::#UWorld::COMLEX::28010 #AK_Step1_v12::#AMBOSS #AK_Step2_v12::#FirstAid::03_Endocrinology::01_Disorders_of_Glucose_Metabolism::02_Diabetes_Mellitus #PANCE::ENDO::diabetes #AK_Step2_v12::#Resources_by_rotation::IM::uw::endocrine_diabetes_metabolism::endocrine_diabetes_metabolism_zanki #AK_Step2_v12::#UWorld::Step::2192 #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::!Shelf::IM #AK_Step2_v12::#OME::01_Medicine::07_Endocrinology::06_Outpatient_Type_2_Diabetes #PANCE::EOR::IM